147 results
8-K
gtdz5h1 az
31 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:19pm
8-K
EX-10.4
xa78m371 1j
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.3
zfdihtg4ornjt4huko
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.2
n2as3jt57tn2re 7jsd
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
425
dh1mdkogfeiqs53w7krb
30 May 23
Business combination disclosure
4:21pm
8-K
qv10tve360nb dyp9ak
30 May 23
Submission of Matters to a Vote of Security Holders
4:18pm
425
8kv8hqlwz qijoea
22 May 23
Business combination disclosure
7:01am
8-K
iqs5i
22 May 23
Other Events
6:59am